You might want to take a look at Gevo Inc. (GEVO) now

Gevo Inc. (NASDAQ: GEVO) stock fell -0.71% on Friday to $1.40 against a previous-day closing price of $1.41. With 10.3 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.04 million shares. The 52-week range on GEVO shows that it touched its highest point at $2.63 and its lowest point at $1.01 during that stretch. It currently has a 1-year price target of $4.48. Beta for the stock currently stands at 3.11.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GEVO was up-trending over the past week, with a rise of 6.06%, but this was down by -2.78% over a month. Three-month performance dropped to -10.26% while six-month performance fell -23.08%. The stock lost -47.17% in the past year, while it has lost -26.32% so far this year. A look at the trailing 12-month EPS for GEVO yields -0.43 with Next year EPS estimates of -0.28. For the next quarter, that number is -0.06. This implies an EPS growth rate of -46.30% for this year and -12.00% for next year. EPS is expected to grow by 25.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 57.00%.

Float and Shares Shorts:

At present, 237.42 million GEVO shares are outstanding with a float of 229.65 million shares on hand for trading. On Aug 30, 2023, short shares totaled 36.25 million, which was 15.27% higher than short shares on Jul 30, 2023. In addition to Dr. Patrick R. Gruber M.B.A., MBA, Ph.D. as the firm’s CEO & Director, Dr. Christopher M. Ryan serves as its Pres & COO.

Institutional Ownership:

Through their ownership of 45.69% of GEVO’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 4.42% of GEVO, in contrast to 26.94% held by mutual funds. Shares owned by individuals account for 13.95%. As the largest shareholder in GEVO with 8.88% of the stake, BlackRock Fund Advisors holds 21,084,435 shares worth 21,084,435. A second-largest stockholder of GEVO, The Vanguard Group, Inc., holds 13,513,678 shares, controlling over 5.69% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in GEVO, holding 11,827,108 shares or 4.98% stake. With a 3.50% stake in GEVO, the SPDR S&P Oil & Gas Exploration & is the largest stakeholder. A total of 8,316,092 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.89% of GEVO stock, is the second-largest Mutual Fund holder. It holds 6,871,435 shares valued at 9.0 million. iShares II Plc – Global Clean Ene holds 2.43% of the stake in GEVO, owning 5,763,992 shares worth 7.55 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, GEVO reported revenue of $89.00k and operating income of -$16.11M. The EBITDA in the recently reported quarter was -$11.76M and diluted EPS was -$0.06.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GEVO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GEVO analysts setting a high price target of $14.00 and a low target of $1.30, the average target price over the next 12 months is $4.44. Based on these targets, GEVO could surge 900.0% to reach the target high and fall by -7.14% to reach the target low. Reaching the average price target will result in a growth of 217.14% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded GEVO stock several times over the past three months with 8 Buys and 8 Sells. In these transactions, 1,870,994 shares were bought while 267,472 shares were sold. The number of buy transactions has increased to 13 while that of sell transactions has risen to 14 over the past year. The total number of shares bought during that period was 2,375,029 while 351,790 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *